The peer-reviewed evaluation analyzed the efficacy, pharmacokinetics, and safety data obtained from

Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stag

Osteoarthritic Pain Model Results Further Validate FABP5 as a Novel Therapeutic Target in Pain Manag

Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess

Every proxy submitted helps establish the quorum needed to conduct the Company's Annual Meeting, reg

Expands potential benefit for treating neuropathic pain in cancer patients, particularly those exper

Expands potential benefit for treating neuropathic pain in cancer patients, particularly those exper

Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stag

The nonclinical study conducted at Stony Brook University adds to substantial evidence of activity a

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulati

Multi-omics analyses identifies linoleic acid as a critical fatty acid which is modulated by ART26.1

The presentations include results from the Phase 1 clinical study of ART26.12 as well as new biomark

First-in-Human Results Demonstrate Favorable Safety and Pharmacokinetics Profile AI Aided Target Eng

Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage

Artelo's lead medicinal chemist reveals findings at the Royal Society of Chemistry-BMCS/DMDG Medicin

U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretio

US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, en

Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro

Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, COD

Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(4.00) per share which missed the ana

SOLANA BEACH, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Art

https://www.sec.gov/Archives/edgar/data/1621221/000164033426000820/artl_s3.htm

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulatin

SOLANA BEACH, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a

Artelo Biosciences, Inc. (NASDAQ:ARTL) shares jumped on Monday after the company announced the publi

Demonstrates ART26.12's Differentiated Profile as a Promising Pain Treatment Ahead of Planned Mu

Demonstrates ART26.12's Differentiated Profile as a Promising Pain Treatment Ahead of Planned Multip

SOLANA BEACH, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a

A look at the most-searched tickers on Benzinga Pro for the month of March shows several newcomers a

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its s

SOLANA BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) tod

U.S. stock futures up, Dow gains 150 points. Avis Budget Group (CAR) shares fall 9.6% in pre-market.

PMGC Holdings shares surged 100.6% to $3.35 in pre-market trading after announcing a licensing agree

Artelo Biosciences, Inc. (NASDAQ: ARTL - Get Free Report) saw a large decline in short interest in t

U.S. stocks down, NASDAQ drops 1.5% on Friday. Energy shares up, consumer discretionary down. Univer

Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced that it has entered into definitive agreemen

SOLANA BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.  (Nasdaq: ARTL) to

US stocks lower as Dow falls 400+ points on Friday. Dow down 0.89%, NASDAQ falls 1.27%, S&P 500

Artelo Biosciences requested the withdrawal of its Registration Statement on Form S-1, initially fil

Artelo Biosciences Inc. shares are trading higher Friday after withdrawing its SEC Registration Stat